Clinical Trials Directory

Trials / Completed

CompletedNCT00778258

Study of Milk Allergy and Tolerance in Children

Dietary Intervention in Milk Allergy and Tolerance Development

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
170 (actual)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Sex
All
Age
4 Years – 10 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if children who are allergic to milk can increase tolerance through frequent dose-escalation every 6 months versus 12 months leading to eventual tolerance of less heated milk and ultimately unheated milk.

Detailed description

Milk is among the most common food allergens in infants and children. The majority of children outgrow their milk allergies; however, the exact mechanisms by which food tolerance is achieved are unknown. Strict avoidance of the offending food is currently the only known therapy. However, some have been known to tolerate milk products cooked at high heat such as when baked in foods. This clinical trial involves a diet containing extensively baked milk protein to investigate the effects of ingestion of heat-denatured milk on development of oral tolerance to non-baked milk.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBaked MilkAt baseline, each subject will undergo sequential oral food challenges with the products that contain increasing amounts of milk protein that are baked: Stage 1 (muffin), Stage 2 (pizza), and Stage 3 (rice pudding) doses of baked milk to determine the extent to which they tolerate various baked milk proteins. Based on the outcomes of the baseline oral food challenges, subjects will be assigned to one of the 5 study arms.
BIOLOGICALNon-baked MilkThose subjects tolerant to rice pudding will undergo oral food challenge with non-baked milk.

Timeline

Start date
2008-08-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2008-10-23
Last updated
2016-03-30
Results posted
2016-03-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00778258. Inclusion in this directory is not an endorsement.